EMCDDA. European Monitoring Centre for Drugs and Drug Addiction
What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue regulated in the EU? These and other questions are explored in this report which responds to growing interest in this topic as more European countries develop policies and practice in this area.
La Comisión Europea está preparando una tercera fase de este programa, por lo que COPOLAD volverá a principios de 2021.
